![PDF) Risk of SARS‐CoV ‐2 infection, hospitalization, and death for COVID ‐19 in people with Parkinson disease or parkinsonism over a 15‐month period: A cohort study PDF) Risk of SARS‐CoV ‐2 infection, hospitalization, and death for COVID ‐19 in people with Parkinson disease or parkinsonism over a 15‐month period: A cohort study](https://i1.rgstatic.net/publication/362053682_Risk_of_SARS-CoV_-2_infection_hospitalization_and_death_for_COVID_-19_in_people_with_Parkinson's_disease_or_parkinsonism_over_a_15-month_period_a_cohort_study/links/62eaa2a2505511283e89c998/largepreview.png)
PDF) Risk of SARS‐CoV ‐2 infection, hospitalization, and death for COVID ‐19 in people with Parkinson disease or parkinsonism over a 15‐month period: A cohort study
![IJMS | Free Full-Text | The Role of Alpha-Synuclein and Other Parkinson's Genes in Neurodevelopmental and Neurodegenerative Disorders IJMS | Free Full-Text | The Role of Alpha-Synuclein and Other Parkinson's Genes in Neurodevelopmental and Neurodegenerative Disorders](https://www.mdpi.com/ijms/ijms-21-05724/article_deploy/html/images/ijms-21-05724-ag.png)
IJMS | Free Full-Text | The Role of Alpha-Synuclein and Other Parkinson's Genes in Neurodevelopmental and Neurodegenerative Disorders
![Human physiomimetic model integrating microphysiological systems of the gut, liver, and brain for studies of neurodegenerative diseases | Science Advances Human physiomimetic model integrating microphysiological systems of the gut, liver, and brain for studies of neurodegenerative diseases | Science Advances](https://www.science.org/cms/10.1126/sciadv.abd1707/asset/dac5de6c-8ade-4cc9-a398-7f4a062f0363/assets/graphic/abd1707-f1.jpeg)
Human physiomimetic model integrating microphysiological systems of the gut, liver, and brain for studies of neurodegenerative diseases | Science Advances
![JPM | Free Full-Text | Are Parkinson's Disease Patients the Ideal Preclinical Population for Alzheimer's Disease Therapeutics? JPM | Free Full-Text | Are Parkinson's Disease Patients the Ideal Preclinical Population for Alzheimer's Disease Therapeutics?](https://www.mdpi.com/jpm/jpm-11-00834/article_deploy/html/images/jpm-11-00834-g001-550.jpg)
JPM | Free Full-Text | Are Parkinson's Disease Patients the Ideal Preclinical Population for Alzheimer's Disease Therapeutics?
![Can We Treat Neurodegenerative Proteinopathies by Enhancing Protein Degradation? - Engelender - Movement Disorders - Wiley Online Library Can We Treat Neurodegenerative Proteinopathies by Enhancing Protein Degradation? - Engelender - Movement Disorders - Wiley Online Library](https://movementdisorders.onlinelibrary.wiley.com/cms/asset/4b761525-662e-4f0a-9752-f32704e8bfea/mds.v37.6.cover.jpg)
Can We Treat Neurodegenerative Proteinopathies by Enhancing Protein Degradation? - Engelender - Movement Disorders - Wiley Online Library
![A dominant tubulin mutation causes cerebellar neurodegeneration in a genetic model of tubulinopathy | Science Advances A dominant tubulin mutation causes cerebellar neurodegeneration in a genetic model of tubulinopathy | Science Advances](https://www.science.org/cms/10.1126/sciadv.abf7262/asset/c34e87d0-c798-46a8-bffb-fabdbf68422d/assets/images/large/sciadv.abf7262-f1.jpg)
A dominant tubulin mutation causes cerebellar neurodegeneration in a genetic model of tubulinopathy | Science Advances
![A Proposed Roadmap for Parkinson's Disease Proof of Concept Clinical Trials Investigating Compounds Targeting Alpha-Synuclein - IOS Press A Proposed Roadmap for Parkinson's Disease Proof of Concept Clinical Trials Investigating Compounds Targeting Alpha-Synuclein - IOS Press](https://content.iospress.com/media/jpd/2019/9-1/jpd-9-1-jpd181471/jpd-9-jpd181471-g001.jpg?width=755)
A Proposed Roadmap for Parkinson's Disease Proof of Concept Clinical Trials Investigating Compounds Targeting Alpha-Synuclein - IOS Press
Proteomic characterization of secretory granules in dopaminergic neurons indicates chromogranin/secretogranin-mediated protein processing impairment in Parkinson's disease | Aging
![Stiff man syndrome and related conditions - Meinck - 2002 - Movement Disorders - Wiley Online Library Stiff man syndrome and related conditions - Meinck - 2002 - Movement Disorders - Wiley Online Library](https://movementdisorders.onlinelibrary.wiley.com/cms/asset/2b2b5c0d-8dd9-4d28-8b4a-ecbe019cbf00/mds.v37.12.cover.jpg)
Stiff man syndrome and related conditions - Meinck - 2002 - Movement Disorders - Wiley Online Library
![Frontiers | Methodological Issues in Randomized Clinical Trials for Prodromal Alzheimer's and Parkinson's Disease Frontiers | Methodological Issues in Randomized Clinical Trials for Prodromal Alzheimer's and Parkinson's Disease](https://www.frontiersin.org/files/Articles/694329/fneur-12-694329-HTML/image_m/fneur-12-694329-t001.jpg)